$IRTC
iRhythm Technologies Inc

2021 Q2 Form 10-Q Financial Statement

#000138865821000129 Filed on August 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $81.28M $50.88M $63.54M
YoY Change 59.75% -2.98% 31.45%
Cost Of Revenue $26.00M $15.48M $16.06M
YoY Change 67.88% 19.0% 36.44%
Gross Profit $55.28M $35.39M $47.47M
YoY Change 56.19% -10.23% 29.84%
Gross Profit Margin 68.02% 69.57% 74.72%
Selling, General & Admin $62.67M $43.01M $48.23M
YoY Change 45.69% 2.02% 26.7%
% of Gross Profit 113.36% 121.53% 101.6%
Research & Development $9.606M $12.54M $8.415M
YoY Change -23.41% 60.12% 25.62%
% of Gross Profit 17.38% 35.44% 17.73%
Depreciation & Amortization $2.149M $1.670M $1.550M
YoY Change 28.68% 142.03% 150.0%
% of Gross Profit 3.89% 4.72% 3.27%
Operating Expenses $72.28M $55.56M $56.65M
YoY Change 30.09% 11.13% 26.54%
Operating Profit -$16.99M -$20.16M -$9.173M
YoY Change -15.72% 90.84% 11.81%
Interest Expense $307.0K $381.0K $380.0K
YoY Change -19.42% -13.41% -7.09%
% of Operating Profit
Other Income/Expense, Net $55.00K $237.0K $505.0K
YoY Change -76.79% -19.66% 34.67%
Pretax Income -$17.24M -$20.31M -$9.048M
YoY Change -15.08% 89.6% 9.83%
Income Tax $116.0K $131.0K $17.00K
% Of Pretax Income
Net Earnings -$17.36M -$20.44M -$9.065M
YoY Change -15.06% 90.55% 9.88%
Net Earnings / Revenue -21.36% -40.17% -14.27%
Basic Earnings Per Share -$0.59 -$0.75
Diluted Earnings Per Share -$0.59 -$0.75 -$337.9K
COMMON SHARES
Basic Shares Outstanding 29.32M shares 27.18M shares 26.80M shares
Diluted Shares Outstanding 29.32M shares 27.18M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $255.7M $114.9M $121.8M
YoY Change 122.46% 94.05% 107.77%
Cash & Equivalents $138.9M $81.73M $56.51M
Short-Term Investments $116.8M $33.20M $65.26M
Other Short-Term Assets $7.219M $3.700M $4.200M
YoY Change 95.11% 0.0% 10.53%
Inventory $9.261M $4.989M $4.227M
Prepaid Expenses
Receivables $63.42M $22.88M $24.21M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $335.6M $146.5M $154.4M
YoY Change 129.0% 58.9% 68.68%
LONG-TERM ASSETS
Property, Plant & Equipment $47.09M $30.20M $28.45M
YoY Change 55.92% 124.63% 176.84%
Goodwill $862.0K $862.0K $862.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $14.18M $10.87M $9.944M
YoY Change 30.41% 141.72% 178.23%
Total Long-Term Assets $149.7M $129.7M $128.5M
YoY Change 15.4% 14.72% 442.78%
TOTAL ASSETS
Total Short-Term Assets $335.6M $146.5M $154.4M
Total Long-Term Assets $149.7M $129.7M $128.5M
Total Assets $485.2M $276.2M $282.9M
YoY Change 75.66% 34.57% 145.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.945M $5.012M $5.544M
YoY Change 78.47% 38.15% 182.86%
Accrued Expenses $42.60M $25.17M $23.25M
YoY Change 69.24% 7.74% 13.2%
Deferred Revenue $2.507M $1.197M $1.115M
YoY Change 109.44% 10.73% -11.65%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $11.67M $7.800M $4.900M
YoY Change 49.58%
Total Short-Term Liabilities $73.02M $47.31M $42.85M
YoY Change 54.33% 33.77% 49.14%
LONG-TERM LIABILITIES
Long-Term Debt $15.52M $27.16M $30.08M
YoY Change -42.88% -22.23% -13.88%
Other Long-Term Liabilities $2.265M $83.80M $85.00M
YoY Change -97.3% -4.88% 2025.0%
Total Long-Term Liabilities $17.78M $27.16M $30.08M
YoY Change -34.55% -22.23% -13.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.02M $47.31M $42.85M
Total Long-Term Liabilities $17.78M $27.16M $30.08M
Total Liabilities $178.8M $158.3M $158.0M
YoY Change 12.95% -0.15% 133.74%
SHAREHOLDERS EQUITY
Retained Earnings -$349.8M -$290.4M -$269.9M
YoY Change 20.48% 29.16% 26.09%
Common Stock $656.3M $408.1M $394.5M
YoY Change 60.8% 50.33% 50.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $306.4M $117.9M $125.0M
YoY Change
Total Liabilities & Shareholders Equity $485.2M $276.2M $282.9M
YoY Change 75.66% 34.57% 145.55%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$17.36M -$20.44M -$9.065M
YoY Change -15.06% 90.55% 9.88%
Depreciation, Depletion And Amortization $2.149M $1.670M $1.550M
YoY Change 28.68% 142.03% 150.0%
Cash From Operating Activities -$545.0K -$10.15M -$22.37M
YoY Change -94.63% -1095.1% 30.32%
INVESTING ACTIVITIES
Capital Expenditures -$5.924M -$2.180M $3.405M
YoY Change 171.74% -38.94% 99.71%
Acquisitions
YoY Change
Other Investing Activities $7.621M $31.84M $63.32M
YoY Change -76.06% -354.52% 125.5%
Cash From Investing Activities $1.697M $29.67M $59.91M
YoY Change -94.28% -284.51% 127.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.969M
YoY Change 40.05%
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities 342.0K 5.700M -$1.493M
YoY Change -94.0% 93.22% 31.2%
NET CHANGE
Cash From Operating Activities -545.0K -10.15M -$22.37M
Cash From Investing Activities 1.697M 29.67M $59.91M
Cash From Financing Activities 342.0K 5.700M -$1.493M
Net Change In Cash 1.494M 25.22M $36.05M
YoY Change -94.08% -308.26% 346.3%
FREE CASH FLOW
Cash From Operating Activities -$545.0K -$10.15M -$22.37M
Capital Expenditures -$5.924M -$2.180M $3.405M
Free Cash Flow $5.379M -$7.970M -$25.77M
YoY Change -167.49% -273.64% 36.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001388658
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37918
dei Entity Registrant Name
EntityRegistrantName
iRhythm Technologies, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8149544
dei Entity Address Address Line1
EntityAddressAddressLine1
699 8th Street Suite 600
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94103
dei City Area Code
CityAreaCode
415
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
632-5700
dei Local Phone Number
LocalPhoneNumber
632-5700
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29403360 shares
dei Security12b Title
Security12bTitle
Common Stock, Par Value $.001 Per Share
dei Trading Symbol
TradingSymbol
IRTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138872000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88628000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
116792000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
246589000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11923000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
12711000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63423000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29932000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
9261000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
5313000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7219000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7363000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
335567000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
377825000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47086000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34247000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87533000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84714000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
862000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
862000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14176000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14091000 USD
CY2021Q2 us-gaap Assets
Assets
485224000 USD
CY2020Q4 us-gaap Assets
Assets
511739000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8945000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4365000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42598000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40532000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2507000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
930000 USD
CY2021Q2 us-gaap Debt Current
DebtCurrent
11667000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
11667000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7301000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8171000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
73018000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65665000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15515000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21339000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2265000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1830000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87984000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81293000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
178782000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
170127000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-304684000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
306442000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
341612000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
485224000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
511739000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81278000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50878000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
155589000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114413000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
25995000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
15484000 USD
us-gaap Cost Of Revenue
CostOfRevenue
49453000 USD
us-gaap Cost Of Revenue
CostOfRevenue
31547000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
55283000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
35394000 USD
us-gaap Gross Profit
GrossProfit
106136000 USD
us-gaap Gross Profit
GrossProfit
82866000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9606000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12542000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18116000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20957000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62669000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43014000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
132482000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91244000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
72275000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
55556000 USD
us-gaap Operating Expenses
OperatingExpenses
150598000 USD
us-gaap Operating Expenses
OperatingExpenses
112201000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16992000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-20162000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-44462000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-29335000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
307000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
381000 USD
us-gaap Interest Expense
InterestExpense
642000 USD
us-gaap Interest Expense
InterestExpense
761000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
237000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
179000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
742000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17244000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20306000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-44925000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-29354000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
116000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
214000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29386146 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29386146 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29019350 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29019350 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
27000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
27000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
656231000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
646258000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-349823000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
148000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17360000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-20437000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45139000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29502000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29318894 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29318894 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27176601 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27176601 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29242089 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29242089 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27008236 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27008236 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17360000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-20437000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45139000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29502000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-183000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
99000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17365000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20620000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45143000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29403000 USD
us-gaap Profit Loss
ProfitLoss
-45139000 USD
us-gaap Profit Loss
ProfitLoss
-29502000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4189000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3220000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
30490000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10073000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1010000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
66000 USD
irtc Provision For Doubtful Accounts And Contractual Allowances
ProvisionForDoubtfulAccountsAndContractualAllowances
14180000 USD
irtc Provision For Doubtful Accounts And Contractual Allowances
ProvisionForDoubtfulAccountsAndContractualAllowances
13524000 USD
irtc Operating Lease Right Of Use Assets Amortization
OperatingLeaseRightOfUseAssetsAmortization
3227000 USD
irtc Operating Lease Right Of Use Assets Amortization
OperatingLeaseRightOfUseAssetsAmortization
2986000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47671000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12994000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4027000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1015000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-145000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-592000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
29000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2728000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1873000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4540000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1985000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9689000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1577000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54000 USD
irtc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2576000 USD
irtc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2326000 USD
irtc Reimbursement Of Tenant Improvement Allowance
ReimbursementOfTenantImprovementAllowance
2351000 USD
irtc Reimbursement Of Tenant Improvement Allowance
ReimbursementOfTenantImprovementAllowance
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42385000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32519000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10134000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5586000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
46429000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
8009000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
14525000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
175300000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
88645000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
118737000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
89575000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5833000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5577000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9361000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25852000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5149000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26108000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4212000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50244000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
61268000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88628000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20462000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138872000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81730000 USD
us-gaap Interest Paid Net
InterestPaidNet
658000 USD
us-gaap Interest Paid Net
InterestPaidNet
796000 USD
irtc Property Plant And Equipment Costs Included In Liabilities
PropertyPlantAndEquipmentCostsIncludedInLiabilities
5319000 USD
irtc Property Plant And Equipment Costs Included In Liabilities
PropertyPlantAndEquipmentCostsIncludedInLiabilities
1369000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6047000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
621000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1632000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
309572000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4001000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
747000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10981000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17360000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
306442000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
341612000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5577000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
25852000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30248000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45139000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
306442000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
124977000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6392000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
687000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7884000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-20437000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-183000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
117946000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
135409000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9361000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5149000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8189000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29502000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
99000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
117946000 USD
CY2020Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1257142 shares
CY2020Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
175.00
CY2020Q3 irtc Underwriters Option To Purchase Additional Shares Of Common Stock
UnderwritersOptionToPurchaseAdditionalSharesOfCommonStock
163975 shares
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
206800000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances, allowance for doubtful accounts, the useful lives of property and equipment, the recoverability of long-lived assets including the estimated usage of the printed circuit board assemblies (“PCBAs”), the incremental borrowing rate for operating leases, accounting for income taxes, and various inputs used in estimating stock-based compensation. Certain of these estimates are impacted by uncertainties surrounding COVID-19 such as revenue recognition, contractual allowances for revenue, allowance for doubtful accounts, and stock based compensation. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that management believes are reasonable under the circumstances, including assumptions as to future events. Actual results may differ from those estimates.</span></div>
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 USD
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
0 USD
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
0 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
12711000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9049000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9049000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3703000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10515000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5957000 USD
irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
4491000 USD
CY2020 irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
7314000 USD
irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
4202000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11923000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
12711000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11265000 USD
CY2020Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
21281000 USD
CY2019Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
15433000 USD
CY2019Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
15433000 USD
irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
10477000 USD
CY2020 irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
20916000 USD
irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
7567000 USD
irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
6450000 USD
CY2020 irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
15068000 USD
irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
7245000 USD
CY2021Q2 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
25308000 USD
CY2020Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
21281000 USD
CY2020Q2 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
15755000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, investments and accounts receivable. Cash balances are deposited in financial institutions which, at times may be in excess of federally insured limits. Cash equivalents are invested in highly-rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, U.S. government securities, corporate notes, commercial paper and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments.</span></div>Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company’s customer base and their dispersion across many geographies. The Company does not require collateral. The Company records an allowance for doubtful accounts based on the assessment of the collectability of customer accounts, considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay.
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81278000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50878000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
155589000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114413000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1200000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
221400000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
221407000 USD
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
104615000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
116792000 USD
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
221407000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
306401000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
18000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
306412000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
59823000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
246589000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
306412000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
221407000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
306412000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
221407000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
306412000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 investment_security
irtc Available For Sale Debt Securities Maturity Period
AvailableForSaleDebtSecuritiesMaturityPeriod
P66D
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
7 investment_security
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 investment_security
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
221407000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
306412000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4200000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1600000 USD
CY2021Q2 irtc Inventory And Printed Circuit Board Assemblies
InventoryAndPrintedCircuitBoardAssemblies
9261000 USD
CY2020Q4 irtc Inventory And Printed Circuit Board Assemblies
InventoryAndPrintedCircuitBoardAssemblies
5313000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65125000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
48097000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18039000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13850000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47086000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34247000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2200000 USD
CY2021Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
7194000 USD
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
6007000 USD
CY2021Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
22374000 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
19709000 USD
CY2021Q2 irtc Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
578000 USD
CY2020Q4 irtc Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
851000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1612000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1709000 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
96000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
121000 USD
CY2021Q2 irtc Claims Payable Current
ClaimsPayableCurrent
4669000 USD
CY2020Q4 irtc Claims Payable Current
ClaimsPayableCurrent
4757000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6075000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7378000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42598000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40532000 USD
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11272471 shares
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9740557 shares
irtc Stock Issued During Period Shares Restricted Stock Award Grants In Period
StockIssuedDuringPeriodSharesRestrictedStockAwardGrantsInPeriod
344414 shares
irtc Stock Issued During Period Shares Restricted Stock Award Vested
StockIssuedDuringPeriodSharesRestrictedStockAwardVested
235123 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
74840 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1503247 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.40
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M4D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
62401000 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
868614 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.31
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
24752 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
66.89
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
609881 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.18
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M26D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
120163000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
77228 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
29.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5117 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
63.72
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
527536 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
41.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M23D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13896000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
467756 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
37.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M24D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13792000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
526235 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
41.41
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y8M23D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
13895000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10260000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9768000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30490000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10073000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2200000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y9M18D
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17360000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-20437000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45139000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29502000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29318894 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29318894 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27176601 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27176601 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29242089 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29242089 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27008236 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27008236 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1602350 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2087254 shares

Files In Submission

Name View Source Status
0001388658-21-000129-index-headers.html Edgar Link pending
0001388658-21-000129-index.html Edgar Link pending
0001388658-21-000129.txt Edgar Link pending
0001388658-21-000129-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
irtc-20210630.htm Edgar Link pending
irtc-20210630.xsd Edgar Link pending
irtc-20210630xex311.htm Edgar Link pending
irtc-20210630xex312.htm Edgar Link pending
irtc-20210630xex321.htm Edgar Link pending
irtc-20210630_cal.xml Edgar Link unprocessable
irtc-20210630_def.xml Edgar Link unprocessable
irtc-20210630_htm.xml Edgar Link completed
irtc-20210630_lab.xml Edgar Link unprocessable
irtc-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending